Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US9409886B2 · kind B2 · utility
2Cited by
36References
50Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 21, 2013 |
| Grant date | Aug 9, 2016 |
| Priority date | — |
| Expiry date | Nov 21, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.